Epcoritamab: An Investigational Bispecific Antibody for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL)
Event Type:
Webinars
Date:
Wednesday, January 18, 2023, 2-3 pm ET
Member:
Free
Non-Member:
Free
